Name of the drug: Amoxicillin Group of drug: Antibiotics Dosage form of drug: Tablet, Capsule, Suspension Indication: AMOXICILLIN,

in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1-year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence. To reduce the development of drug-resistant bacteria and maintain the effectiveness of AMOXIL and other antibacterial drugs, AMOXIL should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Indicated surgical procedures should be performed.

Name of the drug: Ibuprofen Group of drug: Anti-inflammatory drug Dosage form of drug: Tablet, Suspension, Eye drop Indications: In genera, ibuprofen is suited for the treatment of pain, in particular of pain related to the musculoskeletal system, but also headaches, postoperative pain, dysmenorrhea, etc. It also has antipyretic action. Pain accompanying arthrosis can be reduced and the mobility of the joints can be increased. In the case of chronic rheumatoid arthritis, ibuprofen reduces pain, joint swelling and morning stiffness, and it improves the functionality of the joints. Ibuprofen has been used successfully for other rheumatoid diseases such as spondylitis ankylosans (Bechterew disease), juvenile rheumatoid arthritis, and acute gout seizures. However, nonsteroidal antiinflammatory agents only have a symptomatic effect on joint diseases. The development of the disease is not significantly influenced; there are even indications that a long-term treatment may have an unfavourable influence. For soft tissue rheumatism (e.g. periarthropathy of the shoulder) nonsteroidal anti-inflammatory agents can be of use; however, it has not been demonstrated whether they represent advantages in comparison with other methods of treatment. In average, ibuprofen has proven equally as efficient as other anti-inflammatory drugs in all areas of application (e.g. diclofenac, indomethacin, naproxen).

Name of the drug: Acyclovir Group of drug: Anti-viral drug Dosage form of drug: Capsule, Tablet, Suspension Indication: For the treatment of immunocompetent subjects acyclovir only plays a minor role. Herpes simplex. For genital primary infections, oral acyclovir entails a considerably faster healing rate than a placebo or an acyclovir ointment. For herpes simplex keratitis, local or oral therapy is successful. Herpes simplex encephalitis and herpes simplex neonatorum must be treated intravenously. Patients with frequently relapsing herpes simplex (labial or genital) benefit from long-term, prophylactic acyclovir administration. However, treatment of an isolated (labial or genital) herpes relapse is not indicated. The effect of acyclovir against most forms of the varicella-zoster disease is marginal. A herpes zoster of the cornea should be treated as early as possible with high doses of acyclovir. Acyclovir only brings limited benefit for zosters (and varicella) in other localizations. Specialists do not agree on its advantages as far as post-herpetic neuralgias are concerned. The case is different for immunocompromised subjects (chemotherapy, HIV infection, and lymphoma) whose herpes simplex and varicella-zoster infections should all be treated with oral or parenteral acyclovir.

References: http://www.infomed.ch/100drugs/acycind.html http://www.infomed.ch/100drugs/ibuind.html http://rx-s.net/weblog/more/amoxicillin_indications_and_dosage/